Bristol-Myers Squibb Co. (BMY) Tops Q1 EPS by 3c; Boosts FY14 Profit Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $60.86 -1.33%
Revenue Growth %: +4.3%
Financial Fact:
Cost of products sold: 1.31B
Today's EPS Names:
OMID, BCML, CZNC, More
Revenue Growth %: +4.3%
Financial Fact:
Cost of products sold: 1.31B
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q1 EPS of $0.46, $0.03 better than the analyst estimate of $0.43. Revenue for the quarter came in at $3.81 billion versus the consensus estimate of $3.89 billion.
Bristol-Myers Squibb Co. sees FY2014 EPS of $1.70-$1.80, versus prior guidance of $1.65-$1.80 and the consensus of $1.78. Sees worldwide revenues between $15.2 billion and $15.8 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Plumas Bancorp (PLBC) Tops Q3 EPS by 15c
- Teledyne Technologies (TDY) Tops Q3 EPS by 56c, Beats on Revenue; Offers FY26 EPS Guidance
- Elevance Health Inc. (ELV) Tops Q3 EPS by $2.29, Beats on Revenue; Offers FY EPS Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
